Ranbaxy Laboratories Acquisitions, 2 Deals Between 2006 and 2007
life science Company

Ranbaxy Laboratories has acquired 2 companies of its own. A total of 1 acquisition came from private equity firms.

Ranbaxy Laboratories’ largest acquisition to date was in 2006, when it acquired Terapia SA for $324M. Ranbaxy Laboratories has acquired in 2 countries. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Ranbaxy Laboratories’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

Ranbaxy Laboratories Ltd.

Devika Tower 12th Floor 6, Nehru Place,
New Delhi, 110019
India,
91 11 2623 7508
www.ranbaxy.com

Ranbaxy Limited is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals in developed and emerging 4 markets, many of which incorporate proprietary Novel Drug Delivery Systems and technologies developed at its own labs.

M&A Summary

Buy vs Sell

Year ≤ '14 '15 '16 '17 '18 '19 T
Buy (0.0/yr) # 2 - - - - - 2
vol $324M $324M
Sell (0.0/yr) # - - - - - - 0
  2

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Terapia SA
$324M (2006-03-29)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

Life Science M&A - Last 3 Years

Ranbaxy Laboratories was acquired by Sun Pharmaceuticals Industries on April 4, 2014.

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 385 life science companies that have made at least 1 acquisition, 19 have acquired at least 5 companies, and 2 have acquired more than 10 companies.

The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 22 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Avista Capital Partners with 6 platform acquisitions.


What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.7K Private Equity Firms
  • 130K M&A Transactions
  • 139K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 36K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.